查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
全球皮肤科 CRO 市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测
市场调查报告书
商品编码
1421119

全球皮肤科 CRO 市场研究报告 - 2024 年至 2032 年行业分析、规模、份额、成长、趋势和预测

Global Dermatology CRO Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032
出版日期: | 出版商: Value Market Research | 英文 181 Pages | 商品交期: 最快1-2个工作天内

价格

预计到 2032 年，全球皮肤科 CRO 市场的市场规模将从 2023 年的 56.7 亿美元达到近 106.5 亿美元，2024-2032 年研究期间复合CAGR为 7.25%。

皮肤科 CRO 代表皮肤科合约研究组织。 CRO 是一家为製药、生技和医疗器材产业提供研究服务的公司。在皮肤病学方面，这些组织专门从事与皮肤疾病和病症相关的临床试验和研究。它们在帮助製药公司和研究人员收集资料、进行试验以及指导与开发新的皮肤病治疗或疗法相关的监管流程方面发挥着至关重要的作用。

市场动态

皮肤科合约研究组织 (CRO) 市场受到几个关键因素的推动。皮肤病患病率的上升刺激了对创新治疗的需求，推动了皮肤病学的研究和开发活动。科技的进步和向个人化医疗的转变进一步加剧了对该领域专业研究服务的需求。製药公司越来越多地将临床试验活动外包给 CRO，受益于他们的专业知识和基础设施，同时专注于核心能力。皮肤病学研究的复杂性和不断变化的监管指南导致越来越依赖 CRO 服务来应对这些挑战。随着製药业继续优先考虑外包以及皮肤病学研究变得更加复杂，皮肤病学 CRO 市场持续成长，在推动各种皮肤病新疗法和治疗方法的开发方面发挥着至关重要的作用。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球皮肤病学市场的每个细分市场进行了包容性评估。皮肤科微生物产业的成长和趋势为本研究提供了整体方法。

市场区隔

皮肤科 cro 市场报告的这一部分提供了国家和区域层面细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人群以及即将到来的机会。

按类型

  • 药物发现（标靶验证、先导化合物辨识、先导化合物优化）
  • 临床前
  • 临床（I期、II期、III期、IV期）

按服务

  • 专案管理/临床供应管理
  • 资料管理
  • 监管/医疗事务
  • 医学写作
  • 临床监测
  • 品质管理/保证
  • 生物统计学
  • 研究者付款
  • 实验室
  • 患者和现场招募
  • 科技
  • 其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲皮肤科 CRO 市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。皮肤科 CRO 市场的主要参与者包括 IQVIA Inc.、Labcorp Drug Development、Pharmaceutical Product Development, LLC (PPD) (Thermo Fisher Scientific Inc.)、Parexel International Corp.、Charles River Laboratories、Icon, Plc、Medidata、Syneos Health 、康龙化成、雷根生命科学有限公司、药明康德、MEDPACE、CTI 临床试验与咨询、Bioskin、Proinnovera GmbH、Biorasi, LLC、Javara、TFS。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

  • 报告说明
    • 客观的
    • 目标受众
    • 独特的销售主张 (USP) 和产品
  • 研究范围
  • 研究方法论
    • 市场研究过程
    • 市场研究方法论

第 2 章：执行摘要

  • 市集亮点
  • 全球市场概况

第 3 章：皮肤科 CRO - 产业分析

  • 简介 - 市场动态
  • 市场驱动因素
  • 市场限制
  • 机会
  • 产业动态
  • 波特五力分析
  • 市场吸引力分析
    • 按类型分類的市场吸引力分析
    • 按服务分類的市场吸引力分析
    • 市场吸引力分析：按地区

第 4 章：价值链分析

  • 价值链分析
  • 原料分析
    • 原料清单
    • 原料厂商清单
    • 主要原物料价格走势
  • 潜在买家名单
  • 行销管道
    • 直效行销
    • 间接行销
    • 行销通路发展趋势

第 5 章：全球皮肤科 CRO 市场分析：按类型

  • 按类型概述
  • 历史和预测数据
  • 按类型分析
  • 药物发现（标靶验证、先导化合物辨识、先导化合物优化）
  • 临床前
  • 临床（I期、II期、III期、IV期）

第 6 章：全球皮肤科 CRO 市场分析：依服务分类

  • 按服务概览
  • 历史和预测数据
  • 按服务分析
  • 专案管理/临床供应管理
  • 资料管理
  • 监管/医疗事务
  • 医学写作
  • 临床监测
  • 品质管理/保证
  • 生物统计学
  • 研究者付款
  • 实验室
  • 患者和现场招募
  • 科技
  • 其他的

第 7 章：全球皮肤科 CRO 市场分析：依地理位置

  • 区域展望
  • 介绍
  • 北美销售分析
    • 概览、历史与预测资料销售分析
    • 北美按细分市场销售分析
    • 北美按国家销售分析
    • 美国销售分析
    • 加拿大销售分析
    • 墨西哥销售分析
  • 欧洲销售分析
    • 概览、历史与预测资料销售分析
    • 欧洲按细分市场销售分析
    • 欧洲按国家销售分析
    • 英国销售分析
    • 法国销售分析
    • 德国销售分析
    • 义大利销售分析
    • 俄罗斯销售分析
    • 欧洲其他地区销售分析
  • 亚太地区销售分析
    • 概览、历史与预测资料销售分析
    • 亚太地区按细分市场销售分析
    • 亚太地区国家/地区销售分析
    • 中国销售分析
    • 印度销售分析
    • 日本销售分析
    • 韩国销售分析
    • 澳洲销售分析
    • 东南亚销售分析
    • 亚太地区其他地区销售分析
  • 拉丁美洲销售分析
    • 概览、历史与预测资料销售分析
    • 拉丁美洲按细分市场销售分析
    • 拉丁美洲按国家销售分析
    • 巴西销售分析
    • 阿根廷销售分析
    • 秘鲁销售分析
    • 智利销售分析
    • 拉丁美洲其他地区销售分析
  • 中东和非洲销售分析
    • 概览、历史与预测资料销售分析
    • 中东和非洲按细分市场销售分析
    • 中东和非洲国家销售分析
    • 沙乌地阿拉伯销售分析
    • 阿联酋销售分析
    • 以色列销售分析
    • 南非销售分析
    • 中东其他地区和非洲销售分析

第 8 章：皮肤科 CRO 公司的竞争格局

  • 皮肤科Cro市场竞赛
  • 伙伴关係/协作/协议
  • 併购
  • 新产品发布
  • 其他发展

第 9 章：公司简介

  • 顶级公司市占率分析
  • 市场集中度
  • IQVIA Inc.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Labcorp Drug Development
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Pharmaceutical Product Development LLC (PPD) (Thermo Fisher Scientific Inc.)
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Parexel International Corp.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Charles River Laboratories
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Icon PLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Medidata
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Syneos Health
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Pharmaron
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • ragen Life Sciences Ltd.
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Wuxi AppTec
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • MEDPACE
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • CTI Clinical Trial & Consulting
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Bioskin
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Proinnovera GmbH
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Biorasi LLC
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • Javara
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展
  • TFS
    • 公司简介
    • 公司收入
    • 产品
    • 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

Product Code: VMR112113390

The global demand for Dermatology CRO Market is presumed to reach the market size of nearly USD 10.65 BN by 2032 from USD 5.67 BN in 2023 with a CAGR of 7.25% under the study period 2024 - 2032.

Dermatology CRO stands for Dermatology Contract Research Organization. CROs are companies that provide research services to the pharmaceutical, biotechnology, and medical device industries. In the context of dermatology, these organizations specialize in conducting clinical trials and research related to skin disorders and conditions. They play a crucial role in helping pharmaceutical companies and researchers gather data, conduct trials, and navigate the regulatory processes associated with developing new dermatological treatments or therapies.

MARKET DYNAMICS

The Dermatology Contract Research Organization (CRO) market is propelled by several key factors. The rising prevalence of skin disorders has spurred the demand for innovative treatments, driving research and development activities in dermatology. Advancements in technology and the shift towards personalized medicine have further intensified the need for specialized research services in this field. Pharmaceutical companies increasingly outsource clinical trial activities to CROs, benefiting from their expertise and infrastructure while focusing on core competencies. The complexity of dermatology research and evolving regulatory guidelines contribute to the growing reliance on CRO services to navigate these challenges. As the pharmaceutical industry continues to prioritize outsourcing and as dermatological research becomes more intricate, the dermatology CRO market experiences sustained growth, playing a crucial role in advancing the development of new therapies and treatments for various skin conditions.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of dermatology cro. The growth and trends of dermatology cro industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the dermatology cro market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

  • Drug Discovery (Target Validation, Lead Identification, Lead Optimization)
  • Preclinical
  • Clinical (Phase I, Phase Ii, Phase Iii, Phase Iv)

By Service

  • Project Management/Clinical Supply Management
  • Data Management
  • Regulatory/Medical Affairs
  • Medical Writing
  • Clinical Monitoring
  • Quality Management/Assurance
  • Bio-Statistics
  • Investigator Payments
  • Laboratory
  • Patient And Site Recruitment
  • Technology
  • Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Dermatology CRO market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Dermatology CRO market include IQVIA Inc., Labcorp Drug Development, Pharmaceutical Product Development, LLC (PPD) (Thermo Fisher Scientific Inc.), Parexel International Corp., Charles River Laboratories, Icon, Plc, Medidata, Syneos Health, Pharmaron, ragen Life Sciences Ltd., Wuxi AppTec, MEDPACE, CTI Clinical Trial & Consulting, Bioskin, Proinnovera GmbH, Biorasi, LLC, Javara, TFS. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

  • 1.1. Report Description
    • 1.1.1. Objective
    • 1.1.2. Target Audience
    • 1.1.3. Unique Selling Proposition (USP) & offerings
  • 1.2. Research Scope
  • 1.3. Research Methodology
    • 1.3.1. Market Research Process
    • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

  • 2.1. Highlights of Market
  • 2.2. Global Market Snapshot

3 . DERMATOLOGY CRO - INDUSTRY ANALYSIS

  • 3.1. Introduction - Market Dynamics
  • 3.2. Market Drivers
  • 3.3. Market Restraints
  • 3.4. Opportunities
  • 3.5. Industry Trends
  • 3.6. Porter's Five Force Analysis
  • 3.7. Market Attractiveness Analysis
    • 3.7.1 Market Attractiveness Analysis By Type
    • 3.7.2 Market Attractiveness Analysis By Service
    • 3.7.3 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

  • 4.1. Value Chain Analysis
  • 4.2. Raw Material Analysis
    • 4.2.1. List of Raw Materials
    • 4.2.2. Raw Material Manufactures List
    • 4.2.3. Price Trend of Key Raw Materials
  • 4.3. List of Potential Buyers
  • 4.4. Marketing Channel
    • 4.4.1. Direct Marketing
    • 4.4.2. Indirect Marketing
    • 4.4.3. Marketing Channel Development Trend

5 . GLOBAL DERMATOLOGY CRO MARKET ANALYSIS BY TYPE

  • 5.1 Overview by Type
  • 5.2 Historical and Forecast Data
  • 5.3 Analysis by Type
  • 5.4 Drug Discovery (Target Validation, Lead Identification, Lead optimization) Historic and Forecast Sales by Regions
  • 5.5 Preclinical Historic and Forecast Sales by Regions
  • 5.6 Clinical (Phase I, Phase II, Phase III, Phase IV) Historic and Forecast Sales by Regions

6 . GLOBAL DERMATOLOGY CRO MARKET ANALYSIS BY SERVICE

  • 6.1 Overview by Service
  • 6.2 Historical and Forecast Data
  • 6.3 Analysis by Service
  • 6.4 Project Management/Clinical Supply Management Historic and Forecast Sales by Regions
  • 6.5 Data Management Historic and Forecast Sales by Regions
  • 6.6 Regulatory/Medical Affairs Historic and Forecast Sales by Regions
  • 6.7 Medical Writing Historic and Forecast Sales by Regions
  • 6.8 Clinical Monitoring Historic and Forecast Sales by Regions
  • 6.9 Quality Management/Assurance Historic and Forecast Sales by Regions
  • 6.10. Bio-statistics Historic and Forecast Sales by Regions
  • 6.11 Investigator Payments Historic and Forecast Sales by Regions
  • 6.12 Laboratory Historic and Forecast Sales by Regions
  • 6.13 Patient and Site Recruitment Historic and Forecast Sales by Regions
  • 6.14 Technology Historic and Forecast Sales by Regions
  • 6.15 Others Historic and Forecast Sales by Regions

7 . GLOBAL DERMATOLOGY CRO MARKET ANALYSIS BY GEOGRAPHY

  • 7.1. Regional Outlook
  • 7.2. Introduction
  • 7.3. North America Sales Analysis
    • 7.3.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.3.2. North America By Segment Sales Analysis
    • 7.3.3. North America By Country Sales Analysis
    • 7.3.4. United State Sales Analysis
    • 7.3.5. Canada Sales Analysis
    • 7.3.6. Mexico Sales Analysis
  • 7.4. Europe Sales Analysis
    • 7.4.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.4.2. Europe by Segment Sales Analysis
    • 7.4.3. Europe by Country Sales Analysis
    • 7.4.4. United Kingdom Sales Analysis
    • 7.4.5. France Sales Analysis
    • 7.4.6. Germany Sales Analysis
    • 7.4.7. Italy Sales Analysis
    • 7.4.8. Russia Sales Analysis
    • 7.4.9. Rest Of Europe Sales Analysis
  • 7.5. Asia Pacific Sales Analysis
    • 7.5.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.5.2. Asia Pacific by Segment Sales Analysis
    • 7.5.3. Asia Pacific by Country Sales Analysis
    • 7.5.4. China Sales Analysis
    • 7.5.5. India Sales Analysis
    • 7.5.6. Japan Sales Analysis
    • 7.5.7. South Korea Sales Analysis
    • 7.5.8. Australia Sales Analysis
    • 7.5.9. South East Asia Sales Analysis
    • 7.5.10. Rest Of Asia Pacific Sales Analysis
  • 7.6. Latin America Sales Analysis
    • 7.6.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.6.2. Latin America by Segment Sales Analysis
    • 7.6.3. Latin America by Country Sales Analysis
    • 7.6.4. Brazil Sales Analysis
    • 7.6.5. Argentina Sales Analysis
    • 7.6.6. Peru Sales Analysis
    • 7.6.7. Chile Sales Analysis
    • 7.6.8. Rest of Latin America Sales Analysis
  • 7.7. Middle East & Africa Sales Analysis
    • 7.7.1. Overview, Historic and Forecast Data Sales Analysis
    • 7.7.2. Middle East & Africa by Segment Sales Analysis
    • 7.7.3. Middle East & Africa by Country Sales Analysis
    • 7.7.4. Saudi Arabia Sales Analysis
    • 7.7.5. UAE Sales Analysis
    • 7.7.6. Israel Sales Analysis
    • 7.7.7. South Africa Sales Analysis
    • 7.7.8. Rest Of Middle East And Africa Sales Analysis

8 . COMPETITIVE LANDSCAPE OF THE DERMATOLOGY CRO COMPANIES

  • 8.1. Dermatology Cro Market Competition
  • 8.2. Partnership/Collaboration/Agreement
  • 8.3. Merger And Acquisitions
  • 8.4. New Product Launch
  • 8.5. Other Developments

9 . COMPANY PROFILES OF DERMATOLOGY CRO INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Market Concentration Rate
  • 9.3. IQVIA Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Company Revenue
    • 9.3.3. Products
    • 9.3.4. Recent Developments
  • 9.4. Labcorp Drug Development
    • 9.4.1. Company Overview
    • 9.4.2. Company Revenue
    • 9.4.3. Products
    • 9.4.4. Recent Developments
  • 9.5. Pharmaceutical Product Development LLC (PPD) (Thermo Fisher Scientific Inc.)
    • 9.5.1. Company Overview
    • 9.5.2. Company Revenue
    • 9.5.3. Products
    • 9.5.4. Recent Developments
  • 9.6. Parexel International Corp.
    • 9.6.1. Company Overview
    • 9.6.2. Company Revenue
    • 9.6.3. Products
    • 9.6.4. Recent Developments
  • 9.7. Charles River Laboratories
    • 9.7.1. Company Overview
    • 9.7.2. Company Revenue
    • 9.7.3. Products
    • 9.7.4. Recent Developments
  • 9.8. Icon PLC
    • 9.8.1. Company Overview
    • 9.8.2. Company Revenue
    • 9.8.3. Products
    • 9.8.4. Recent Developments
  • 9.9. Medidata
    • 9.9.1. Company Overview
    • 9.9.2. Company Revenue
    • 9.9.3. Products
    • 9.9.4. Recent Developments
  • 9.10. Syneos Health
    • 9.10.1. Company Overview
    • 9.10.2. Company Revenue
    • 9.10.3. Products
    • 9.10.4. Recent Developments
  • 9.11. Pharmaron
    • 9.11.1. Company Overview
    • 9.11.2. Company Revenue
    • 9.11.3. Products
    • 9.11.4. Recent Developments
  • 9.12. ragen Life Sciences Ltd.
    • 9.12.1. Company Overview
    • 9.12.2. Company Revenue
    • 9.12.3. Products
    • 9.12.4. Recent Developments
  • 9.13. Wuxi AppTec
    • 9.13.1. Company Overview
    • 9.13.2. Company Revenue
    • 9.13.3. Products
    • 9.13.4. Recent Developments
  • 9.14. MEDPACE
    • 9.14.1. Company Overview
    • 9.14.2. Company Revenue
    • 9.14.3. Products
    • 9.14.4. Recent Developments
  • 9.15. CTI Clinical Trial & Consulting
    • 9.15.1. Company Overview
    • 9.15.2. Company Revenue
    • 9.15.3. Products
    • 9.15.4. Recent Developments
  • 9.16. Bioskin
    • 9.16.1. Company Overview
    • 9.16.2. Company Revenue
    • 9.16.3. Products
    • 9.16.4. Recent Developments
  • 9.17. Proinnovera GmbH
    • 9.17.1. Company Overview
    • 9.17.2. Company Revenue
    • 9.17.3. Products
    • 9.17.4. Recent Developments
  • 9.18. Biorasi LLC
    • 9.18.1. Company Overview
    • 9.18.2. Company Revenue
    • 9.18.3. Products
    • 9.18.4. Recent Developments
  • 9.19. Javara
    • 9.19.1. Company Overview
    • 9.19.2. Company Revenue
    • 9.19.3. Products
    • 9.19.4. Recent Developments
  • 9.20. TFS
    • 9.20.1. Company Overview
    • 9.20.2. Company Revenue
    • 9.20.3. Products
    • 9.20.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

  • Market Snapshot
  • Drivers : Impact Analysis
  • Restraints : Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • Analysis by Type (USD MN)
  • Drug Discovery (Target Validation, Lead Identification, Lead optimization) Market Sales by Geography (USD MN)
  • Preclinical Market Sales by Geography (USD MN)
  • Clinical (Phase I, Phase II, Phase III, Phase IV) Market Sales by Geography (USD MN)
  • Analysis Market by Service (USD MN)
  • Project Management/Clinical Supply Management Market Sales by Geography (USD MN)
  • Data Management Market Sales by Geography (USD MN)
  • Regulatory/Medical Affairs Market Sales by Geography (USD MN)
  • Medical Writing Market Sales by Geography (USD MN)
  • Clinical Monitoring Market Sales by Geography (USD MN)
  • Quality Management/Assurance Market Sales by Geography (USD MN)
  • Bio-statistics Market Sales by Geography (USD MN)
  • Investigator Payments Market Sales by Geography (USD MN)
  • Laboratory Market Sales by Geography (USD MN)
  • Patient and Site Recruitment Market Sales by Geography (USD MN)
  • Technology Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Dermatology Cro Market Sales by Geography (USD MN)
  • North America Market Analysis (USD MN)
  • United State Market Analysis (USD MN)
  • Canada Market Analysis (USD MN)
  • Mexico Market Analysis (USD MN)
  • Europe Market Analysis (USD MN)
  • Europe Market Estimate by Country (USD MN)
  • United Kingdom Market Analysis (USD MN)
  • France Market Analysis (USD MN)
  • Germany Market Analysis (USD MN)
  • Italy Market Analysis (USD MN)
  • Russia Market Analysis (USD MN)
  • Spain Market Analysis (USD MN)
  • Rest of Europe Market Analysis (USD MN)
  • Asia Pacific Market Analysis (USD MN)
  • China Market Analysis (USD MN)
  • Japan Market Analysis (USD MN)
  • India Market Analysis (USD MN)
  • South Korea Market Analysis (USD MN)
  • Australia Market Analysis (USD MN)
  • South East Asia Market Analysis (USD MN)
  • Rest of Asia Pacific Market Analysis (USD MN)
  • Latin America Market Analysis (USD MN)
  • Brazil Market Analysis (USD MN)
  • Argentina Market Analysis (USD MN)
  • Peru Market Analysis (USD MN)
  • Chile Market Analysis (USD MN)
  • Rest of Latin America Market Analysis (USD MN)
  • Middle East & Africa Market Analysis (USD MN)
  • Saudi Arabia Market Analysis (USD MN)
  • UAE Market Analysis (USD MN)
  • Israel Market Analysis (USD MN)
  • South Africa Market Analysis (USD MN)
  • Rest of Middle East and Africa Market Analysis (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisition

LIST OF FIGURES

  • Research Scope of Dermatology Cro Report
  • Market Research Process
  • Market Research Methodology
  • Global Dermatology Cro Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Service
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Market Analysis by Type (USD MN)
  • Drug Discovery (Target Validation, Lead Identification, Lead optimization) Market Sales by Geography (USD MN)
  • Preclinical Market Sales by Geography (USD MN)
  • Clinical (Phase I, Phase II, Phase III, Phase IV) Market Sales by Geography (USD MN)
  • Global Market Analysis by Service (USD MN)
  • Project Management/Clinical Supply Management Market Sales by Geography (USD MN)
  • Data Management Market Sales by Geography (USD MN)
  • Regulatory/Medical Affairs Market Sales by Geography (USD MN)
  • Medical Writing Market Sales by Geography (USD MN)
  • Clinical Monitoring Market Sales by Geography (USD MN)
  • Quality Management/Assurance Market Sales by Geography (USD MN)
  • Bio-statistics Market Sales by Geography (USD MN)
  • Investigator Payments Market Sales by Geography (USD MN)
  • Laboratory Market Sales by Geography (USD MN)
  • Patient and Site Recruitment Market Sales by Geography (USD MN)
  • Technology Market Sales by Geography (USD MN)
  • Others Market Sales by Geography (USD MN)
  • Global Market Sales (USD MN)
  • North America Market Sales (USD MN)
  • Europe Market Sales (USD MN)
  • Asia Pacific Market Sales (USD MN)
  • Latin America Market Sales (USD MN)
  • Middle East & Africa Market Sales (USD MN)
  • Recent Development in Industry
  • Top Companies Market Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.